Breaking News

Splenectomy as Treatment for Primary Warm Autoimmune Hemolytic Anemia (wAIHA)
WHAT YOU NEED TO KNOW | EMA Recommends Suspension of Pfizer’s Sickle Cell Disease Drug Oxbryta
APLASTIC ANEMIA | Hetrombopag Achieves Significant Hematological Responses in Newly Diagnosed Patients
THALASSAEMIA WEBINAR FOR ASEAN & OCEANIA HEALTHCARE PROFESSIONALS | 21 October 2024
UNITING EXPERTS | Highlights from the 1st Nordic Red Blood Cell Meeting
ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
WORLD PATIENT SAFETY DAY 2024 | Get It Right, Make It Safe!
REGULATORY APPROVAL | PiaSky Becomes the First Monthly Treatment for PNH in the EU
ACCESS TO INNOVATION | UK Greenlights Gene-Editing Therapy Casgevy for β-Thalassaemia Treatment
GLOBAL SURVEY | Understanding the Thalassaemia Community Health Literacy & Its Impact on Care

English

Menu

Home
Who we are
What we do
Haemoglobin Disorders
Positions & Policies
Publications
Media Centre
- News
- Newsletters
- Events
- Videos
Contact us

Search for

Home/Newsletter/TIF Newsletter – August 2023

TIF Newsletter – August 2023

Less than a minute

TIF Newsletter_June 2023

Less than a minute

Facebook X LinkedIn Share via Email Print

Related Articles

TIF Newsletter – October 2023

November 9, 2023

TIF Newsletter – June 2023

July 6, 2023

TIF Newsletter – October 2022

November 7, 2022

TIF Newsletter – August 2022

September 1, 2022

Check Also

Scientific Literature

Hepatocellular Carcinoma in Transfusion Dependent Thalassemia Patients: A Review from a Clinical Perspective
December 5, 2021

Quick links

For Patients
For Healthcare Professionals
For Associations
For Supporters
TIF Members
Useful Links
Sitemap

Follow us

Facebook
X
LinkedIn
YouTube
Instagram
RSS

© Copyright 2024, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Facebook X WhatsApp

Back to top button

Close

Facebook
X
LinkedIn
YouTube
Instagram
RSS

Search for: